Similar articles for PMID: 31315770

Year	Number of Results
2008	1
2009	3
2010	2
2011	4
2012	9
2013	16
2014	11
2015	16
2016	19
2017	14
2018	16
2019	16
2020	11
2021	15
2022	14
2023	11
2024	0

1

[Effect of increasing the intensity of chemotherapy on the prognosis of acute lymphoblastic leukemia in children with IKZF1 deletion].

Zheng YZ, Li J, LE SH, Zheng H, Hua XL, Chen ZS, Hu JD. Zheng YZ, et al. Zhongguo Dang Dai Er Ke Za Zhi. 2019 Jul;21(7):690-695. doi: 10.7499/j.issn.1008-8830.2019.07.014. Zhongguo Dang Dai Er Ke Za Zhi. 2019. PMID: 31315770 Free PMC article. Chinese.

2

[Significance of ikaros family zinc finger 1 deletion in pediatric B-acute lymphoblastic leukemia without reproducible cytogenetic abnormalities].

Liu X, Zhang L, Zou Y, Chang L, Wei W, Ruan M, Chen Y, Yang W, Chen X, Guo Y, Wang S, Liu T, Zhang J, Liu F, Qi B, An W, Zhu X. Liu X, et al. Zhonghua Er Ke Za Zhi. 2016 Feb;54(2):126-30. doi: 10.3760/cma.j.issn.0578-1310.2016.02.011. Zhonghua Er Ke Za Zhi. 2016. PMID: 26875463 Chinese.

3

Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.

Volejnikova J, Mejstrikova E, Dörge P, Meissner B, Zimmermannova O, Svojgr K, Stanulla M, Cario G, Schrappe M, Stary J, Hrusak O, Trka J, Fronkova E. Volejnikova J, et al. Pediatr Blood Cancer. 2013 Mar;60(3):420-7. doi: 10.1002/pbc.24299. Epub 2012 Sep 19. Pediatr Blood Cancer. 2013. PMID: 22997141

4

[Effects of minimal residual disease level on day 33 of remission induction and IKZF1 genotype on the survival of children with B-lineage acute lymphoblastic leukemia].

Kuang WY, Zheng MC, Li WL, Yang HX, Zhang BS, Wu P. Kuang WY, et al. Zhongguo Dang Dai Er Ke Za Zhi. 2018 Jul;20(7):538-542. doi: 10.7499/j.issn.1008-8830.2018.07.005. Zhongguo Dang Dai Er Ke Za Zhi. 2018. PMID: 30022754 Free PMC article. Chinese.

5

[Significance of IKZF1 gene copy number abnormalities in BCR/ABL-negative B-lineage acute lymphoblastic leukemia in children].

Zou Y, Liu XM, Zhang L, Chen YM, Guo Y, Chen XJ, Yang WY, Wang SC, Ruan M, Liu TF, Zhang JY, Liu F, Qi BQ, Zhu XF. Zou Y, et al. Zhongguo Dang Dai Er Ke Za Zhi. 2015 Nov;17(11):1154-9. Zhongguo Dang Dai Er Ke Za Zhi. 2015. PMID: 26575870 Free article. Chinese.

6

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.

Martinelli G, Iacobucci I, Storlazzi CT, Vignetti M, Paoloni F, Cilloni D, Soverini S, Vitale A, Chiaretti S, Cimino G, Papayannidis C, Paolini S, Elia L, Fazi P, Meloni G, Amadori S, Saglio G, Pane F, Baccarani M, Foà R. Martinelli G, et al. J Clin Oncol. 2009 Nov 1;27(31):5202-7. doi: 10.1200/JCO.2008.21.6408. Epub 2009 Sep 21. J Clin Oncol. 2009. PMID: 19770381

7

Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia.

Yao QM, Liu KY, Gale RP, Jiang B, Liu YR, Jiang Q, Jiang H, Zhang XH, Zhang MJ, Chen SS, Huang XJ, Xu LP, Ruan GR. Yao QM, et al. BMC Cancer. 2016 Apr 11;16:269. doi: 10.1186/s12885-016-2300-7. BMC Cancer. 2016. PMID: 27067989 Free PMC article. Clinical Trial.

8

Quantitative analysis of IKZF1 gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia: higher levels are associated with a poorer prognosis.

Huang Z, Jia Y, Ruan G, Zuo Y, Wu J, Lu A, Xue Y, Cheng Y, Zhang L. Huang Z, et al. Pediatr Hematol Oncol. 2022 Apr;39(3):243-253. doi: 10.1080/08880018.2021.1966558. Epub 2021 Sep 28. Pediatr Hematol Oncol. 2022. PMID: 34582325

9

IKZF1 Deletion Subtyping and Outcome Analysis in BCR-ABL1-Negative Pediatric B-Cell Acute Lymphoblastic Leukemia: A Single-Institution Experience from North India.

Gupta SK, Bakhshi S, Gupta R, Sharma P, Pushpam D, Sahoo RK, Kamal VK. Gupta SK, et al. Clin Lymphoma Myeloma Leuk. 2021 Aug;21(8):e666-e673. doi: 10.1016/j.clml.2021.03.007. Epub 2021 Mar 29. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33906825

10

[Outcome of children with T cell acute lymphoblastic leukemia treated with Chinese Children Leukemia Group acute lymphoblastic leukemia (CCLG-ALL) 2008 protocol].

Liu XM, Chen XJ, Zou Y, Wang SC, Wang M, Zhang L, Chen YM, Yang WY, Guo Y, Zhu XF. Liu XM, et al. Zhonghua Er Ke Za Zhi. 2019 Oct 2;57(10):761-766. doi: 10.3760/cma.j.issn.0578-1310.2019.10.007. Zhonghua Er Ke Za Zhi. 2019. PMID: 31594062 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

151 results

Results by year